Found 7 results
Filters: Author is C. Wu  [Clear All Filters]
S. J. Liu, Chen, F. F., Dai, Y., Wu, C., Ni, Q. S., and Yu, W. Y., Molecular characterization and tissue-specific expression of invariant chain in the muscovy duck (Cairina moschata), vol. 10, pp. 2867-2880, 2011.
Adams S, Albericio F, Alsina J, Smith ER, et al. (1997). Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules. Arzneimittelforschung 47: 1069-1077. PMid:9342425 Barrera CA, Almanza RJ, Ogra PL and Reyes VE (1998). The role of the invariant chain in mucosal immunity. Int. Arch. Allergy Immunol. 117: 85-93. PMid:9784651 Barrera CA, Beswick EJ, Sierra JC, Bland D, et al. (2005). Polarized expression of CD74 by gastric epithelial cells. J. Histochem. Cytochem. 53: 1481-1489. PMid:15923369 Bernatchez L and Landry C (2003). MHC studies in nonmodel vertebrates: what have we learned about natural selection in 15 years? J. Evol. Biol. 16: 363-377. PMid:14635837 Bremnes B, Madsen T, Gedde-Dahl M and Bakke O (1994). An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J. Cell Sci. 107 (Pt 7): 2021-2032. PMid:7983165 Bremnes B, Rode M, Gedde-Dahl M, Nordeng TW, et al. (2000). The MHC class II-associated chicken invariant chain shares functional properties with its mammalian homologs. Exp. Cell Res. 259: 360-369. PMid:10964503 Bryant P and Ploegh H (2004). Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16: 96-102. PMid:14734116 Busch R, Rinderknecht CH, Roh S, Lee AW, et al. (2005). Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207: 242-260. PMid:16181341 Claesson L and Peterson PA (1983). Association of human gamma chain with class II transplantation antigens during intracellular transport. Biochemistry 22: 3206-3213. PMid:6576808 Cortes A, Fonfria J, Vicente A, Varas A, et al. (1995). T-dependent areas in the chicken bursa of Fabricius: an immunohistological study. Anat. Rec. 242: 91-95. PMid:7604986 Cresswell P (1996). Invariant chain structure and MHC class II function. Cell 84: 505-507. Denzin LK and Cresswell P (1995). HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82: 155-165. Ghosh P, Amaya M, Mellins E and Wiley DC (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378: 457-462. PMid:7477400 Hershberg RM and Mayer LF (2000). Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol. Today 21: 123-128. Holmes JP, Benavides LC, Gates JD, Carmichael MG, et al. (2008). Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine. J. Clin. Oncol. 26: 3426-3433. PMid:18612158 Hung CF, Tsai YC, He L and Wu TC (2007). DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency. Mol. Ther. 15: 1211-1219. PMid:17356542 PMCid:3171992 Koch N and Harris AW (1984). Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. J. Immunol. 132: 12-15. PMid:6418793 Lennon-Dumenil AM, Roberts RA, Valentijn K, Driessen C, et al. (2001). The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J. 20: 4055-4064. PMid:11483509 PMCid:149174 Lipp J and Dobberstein B (1986). The membrane-spanning segment of invariant chain (I gamma) contains a potentially cleavable signal sequence. Cell 46: 1103-1112. Maharshak N, Cohen S, Lantner F, Hart G, et al. (2010). CD74 is a survival receptor on colon epithelial cells. World J. Gastroenterol. 16: 3258-3266. PMid:20614481 PMCid:2900717 Mallegol J, van Niel G and Heyman M (2005). Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Mol. Dis. 35: 11-16. PMid:15893486 Marchalonis JJ, Kaveri S, Lacroix-Desmazes S and Kazatchkine MD (2002). Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system. FASEB J. 16: 842-848. PMid:12039866 Meyer-Lucht Y, Otten C, Püttker T, Pardini R, et al. (2010). Variety matters: adaptive genetic diversity and parasite load in two mouse opossums from the Brazilian Atlantic forest. Conserv. Genet. 11: 2001-2013. Nagaraj S, Neumann J, Winzen B, Frank S, et al. (2008). Pancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibition. Pancreas 37: 321-327. PMid:18815556 Nagata T, Higashi T, Aoshi T, Suzuki M, et al. (2001). Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization. Vaccine 20: 105-114. Nagata T, Aoshi T, Suzuki M, Uchijima M, et al. (2002). Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain. Infect. Immun. 70: 2676-2680. PMid:11953411 PMCid:127905 O’Sullivan DM, Noonan D and Quaranta V (1987). Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J. Exp. Med. 166: 444-460. PMid:3036998 Pieters J (1997). MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9: 89-96. Qi BM and Chen XY (2006). Distribution and histology of fabricius’ bursa-associated lymphoid tissues (FBALT) in muscovy duck. Fujian J. Agric. Sci. 21: 127-130. Silva DS, Reis MI, Nascimento DS, do Vale A, et al. (2007). Sea bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility complex: sequencing and structural analysis using 3D homology modelling. Mol. Immunol. 44: 3758-3776. PMid:17512596 Strubin M, Mach B and Long EO (1984). The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J. 3: 869-872. PMid:6586420 PMCid:557440 Surridge AK, van der Loo W, Abrantes J, Carneiro M, et al. (2008). Diversity and evolutionary history of the MHC DQA gene in leporids. Immunogenetics 60: 515-525. PMid:18584169 Tamori Y, Tan X, Nakagawa K, Takai E, et al. (2005). Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma. Oncol. Rep. 14: 873-877. PMid:16142345 van Bergen J, Camps M, Offringa R, Melief CJ, et al. (2000). Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide. Cancer Res. 60: 6427-6433. PMid:11103809 Voutsas IF, Gritzapis AD, Mahaira LG, Salagianni M, et al. (2007). Induction of potent CD4+ T cell-mediated antitumor responses by a helper HER-2/neu peptide linked to the Ii-Key moiety of the invariant chain. Int. J. Cancer 121: 2031-2041. PMid:17634957 Xu FZ, Ye H, Wang JJ and Yu WY (2008). The effect of site-directed mutagenesis of the ambient amino acids of leucine-based sorting motifs on the localization of chicken invariant chain. Poult. Sci. 87: 1980-1986. PMid:18809859 Zhang JH, Deng SZ, Chen NH, Quyang JH, et al. (2000). Biological effects of the T-cell area of chicken bursa. Acta Agric. Univ. Jiangxiensis 22: 110-112. Zhong DL, Yu WY, Liu YH, Liu J, et al. (2004). Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing. Immunogenetics 56: 650-656. PMid:15578263 Zhong DL, Yu WY, Bao M, Xu ZB, et al. (2006). Molecular cloning and rnRNA expression of duck invariant chain. Vet. Immunol. Immunop. 110: 293-302. PMid:16313970